Increased pro-inflammatory
cytokines and an overactive hypothalamic-pituitary-adrenal (HPA) axis have both been implicated in the pathogenesis of depression. However, these explanations appear contradictory because
glucocorticoids are well recognised for their anti-inflammatory effects. Two hypotheses exist to resolve this paradox: the mediating presence of
glucocorticoid receptor resistance, or the possibility that
glucocorticoids can potentiate inflammatory processes in some circumstances. We sought to investigate these hypotheses in a cell model with significant relevance to depression: human hippocampal progenitor cells. We demonstrated that
dexamethasone in vitro given for 24 hours and followed by a 24 hours rest interval before an immune challenge potentiates inflammatory effects in these neural cells, that is, increases the
IL-6 protein secretion induced by stimulation with IL-1β (10 ng/mL for 24 hours) by + 49% (P < 0.05) at a concentration of 100 nM and by + 70% (P < 0.01) for 1 μM. These effects are time- and dose-dependent and require activation of the
glucocorticoid receptor. Gene expression microarray assays using Human Gene 2.1st Array Strips demonstrated that
glucocorticoid treatment up-regulated several innate immune genes, including
chemokines and
Nod-like receptor, NLRP6; using
transcription factor binding motifs we found limited evidence that
glucocorticoid resistance was induced in the cells. Our data suggests a mechanism by which stress may prime the immune system for increased
inflammation and suggests that stress and
inflammation may be synergistic in the pathogenesis of depression.